Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Romiplostim vs SOC in ITP
NCT00415532Phase 3Completed
- Sponsor
- Amgen
- Start
- Dec 2006
- Primary completion
- Nov 2008
- Modality
- Recombinant Proteins and Enzymes
01
Overview
A Phase 3 trial of romiplostim in immune thrombocytopenic purpura (ITP), sponsored by Amgen. Started Dec 2006; status: completed.
02
Drugs
romiplostim
03
Conditions
immune thrombocytopenic purpura (ITP)
Beyond the preview
Go deeper on NCT00415532.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00415532.